Gregg Stone

Showing 1-20 of 70 articles

Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M, Cutlip D, Krucoff M, Stone G, Lansky A, Mehran R, Spitzer E, Fraser A, Baumbach A, Serruys P

January 17, 2020 | 10.4244/EIJ-D-19-00552

Coronary interventions

The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G

January 17, 2020 | 10.4244/EIJ-D-19-00467

Coronary interventions

Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik III JF, Kappetein AP, Dressler O, Stone G

December 3, 2019 | 10.4244/EIJ-D-19-00686

Coronary interventions

Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein AP, Sabik III JF, Dressler O, Mehran R, Sharma SK, Stone G

November 26, 2019 | 10.4244/EIJ-D-19-00851

The five Ws of transcatheter mitral valve repair: Who, What, When, Where, and Why

Stone G, Alfieri O

November 15, 2019 | 10.4244/EIJV15I10A158

Coronary interventions

The Obesity Paradox Revisited: Body Mass Index and Long-Term Outcomes After PCI From a Large Pooled Patient-Level Database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G

October 29, 2019 | 10.4244/EIJ-D-19-00467

The SYNTAX score on its way out or … towards artificial intelligence: part II

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y

October 25, 2019 | 10.4244/EIJ-D-19-00543B

The SYNTAX score on its way out or … towards artificial intelligence: part I

October 25, 2019 | 10.4244/EIJ-D-19-00543A

Coronary interventions

Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation

Katagiri Y, Serruys P, Tenekecioglu E, Asano T, Collet C, Miyazaki Y, Katsikis A, Piek J, Wykrzykowska J, Chevalier B, Mintz G, Stone G, Onuma Y

September 20, 2019 | 10.4244/EIJ-D-18-00422

Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M, Cutlip D, Krucoff M, Stone G, Lansky A, Mehran R, Spitzer E, Fraser A, Baumbach A, Serruys P

September 3, 2019 | 10.4244/EIJ-D-19-00552

Coronary interventions

Society of Thoracic Surgeons Risk Scores Performance in Patients with Left Main Coronary Artery Disease Undergoing Revascularization in the EXCEL trial

Thuijs D, Habib RH, Head SJ, Puskas J, Taggart D, Stone G, Zhang Z, Serruys P, Sabik III JF, Kappetein AP

August 20, 2019 | 10.4244/EIJ-D-19-00417

Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention

Brener S, Leon M, Serruys P, Smits P, von Birgelen C, Mehran R, Kirtane A, Witzenbichler B, Rinaldi M, Metzger C, Mazzaferri E, Zhang Z, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00262

Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial

Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas J, Kandzari D, Banning A, Morice M, Taggart D, Sabik J, Serruys P, Kappetein A, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00263

Coronary interventions

A Continuous Intracoronary Versus A Standard Intravenous Infusion of Adenosine for Fractional Flow Reserve Assessment – the HYPEREMIC Trial

Elghamaz A, Myat A, De Belder A, Collison D, Cocks K, Stone G, Oldroyd K

July 9, 2019 | 10.4244/EIJ-D-18-01067

Treatment of mitral regurgitation: cut, clip or medicate?

Stone G, Mack M

April 16, 2019 | 10.4244/EIJV14I17A294

Coronary interventions

Significant association among residual SYNTAX score, non-culprit major adverse cardiac events, and greyscale and virtual histology intravascular ultrasound findings: a substudy from the PROSPECT study

Fujino A, Kadohira T, Redfors B, Maehara A, Serruys P, Mintz G, Stone G, Généreux P

March 20, 2019 | 10.4244/EIJ-D-18-00681

Coronary interventions

Qualitative resting coronary pressure wave form analysis to predict fractional flow reserve

Matsumura M, Maehara A, Johnson N, Fearon W, De Bruyne B, Oldroyd K, Pijls N, Jenkins P, Ali Z, Mintz G, Stone G, Jeremias A

February 7, 2019 | 10.4244/EIJ-D-17-01149

Coronary interventions

Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial

Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice M, Leon M, Kandzari D, Mehran R, Lembo N, Banning A, Merkely B, Kappetein AP, Sabik rd J, Serruys P, Stone G

November 20, 2018 | 10.4244/EIJ-D-18-00711

Stents and scaffolds

Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial

Tanabe K, Popma J, Kozuma K, Saito S, Muramatsu T, Nakamura S, Namiki A, Morino Y, Hagiwara N, Uematsu M, Kawasaki T, Fujii K, Serruys P, Onuma Y, Ying S, Kusano H, Stone G, Kimura T

October 12, 2018 | 10.4244/EIJ-D-17-00716

Coronary interventions

Impact of bleeding assessment and adjudication methodology on event rates and clinical trial outcomes: insights from the HORIZONS-AMI trial

Kosmidou I, Mintz G, Jatene T, Embacher M, Redfors B, Wong SC, Dressler O, Mehran R, Ben-Yehuda O, Jenkins PL, Stone G

August 3, 2018 | 10.4244/EIJ-D-18-00131

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

Gregg Stone

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke